Longitudinal study seeks to uncover biomarkers for early diagnosis of amyotrophic lateral sclerosis in participants with genetic mutations and symptoms.
Key Points
A presymptomatic and early diagnostic signature for amyotrophic lateral sclerosis is being explored.
Over 330 participants, including gene mutation carriers and symptomatic individuals, will be involved.
This longitudinal study will assess various biomarkers using advanced analyses like proteomics and metabolomics.
Findings may significantly enhance early diagnostic capabilities and clinical practices for amyotrophic lateral sclerosis.